Barnes Alane P
Insider CIK 1584348 · BCRX VP, General Counsel & Corp Sec
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2026-05-13 | 2026-05-15 | 62,500 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2026-05-13 | 2026-05-15 | 62,500 | $5.04 | $315.0K | 463,203 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2026-05-13 | 2026-05-15 | 62,500 | $9.54 | $596.3K | 400,703 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2026-03-16 | 2026-03-18 | 150,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2026-03-16 | 2026-03-18 | 150,000 | $5.51 | $826.5K | 550,703 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2026-03-16 | 2026-03-18 | 150,000 | $9.15 | $1.37M | 400,703 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2025-12-22 | 2025-12-23 | 21,773 | $7.65 | $166.6K | 398,751 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2025-12-19 | 2025-12-23 | 16,902 | $7.41 | $125.2K | 420,524 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2025-12-17 | 2025-12-19 | 255,050 | — | $0 | 255,050 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-12-17 | 2025-12-19 | 121,700 | — | $0 | 437,426 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2025-12-15 | 2025-12-16 | 21,210 | $7.65 | $162.3K | 315,726 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2025-12-12 | 2025-12-16 | 8,540 | $7.57 | $64.6K | 336,936 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2025-12-03 | 2025-12-03 | 19,770 | $7.65 | $151.2K | 345,476 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2025-12-02 | 2025-12-03 | 50,906 | $7.21 | $367.0K | 365,246 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2025-12-01 | 2025-12-03 | 91,004 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2025-12-01 | 2025-12-03 | 91,004 | $7.10 | $646.1K | 416,152 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2025-12-01 | 2025-12-03 | 91,004 | $3.22 | $293.0K | 507,156 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-12-19 | 2024-12-23 | 250,100 | — | $0 | 250,100 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-12-19 | 2024-12-23 | 120,700 | — | $0 | 415,190 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-19 | 2024-12-23 | 2,461 | $7.39 | $18.2K | 412,729 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-14 | 2024-12-17 | 8,613 | $7.53 | $64.9K | 294,490 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2024-05-13 | 2024-05-15 | 5,000 | $5.53 | $27.6K | 300,762 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-19 | 2023-12-20 | 2,482 | $6.05 | $15.0K | 293,539 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-12-14 | 2023-12-18 | 158,500 | — | $0 | 158,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-14 | 2023-12-18 | 4,015 | $6.43 | $25.8K | 296,021 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-12-14 | 2023-12-18 | 64,000 | — | $0 | 300,036 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-12-19 | 2022-12-21 | 158,500 | — | $0 | 158,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-12-19 | 2022-12-21 | 34,000 | — | $0 | 232,770 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-12-15 | 2022-12-19 | 4,175 | $10.88 | $45.4K | 198,770 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2022-01-13 | 55,000 | — | $0 | 201,969 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-12-14 | 2021-12-16 | 164,000 | — | $0 | 164,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2021-12-16 | 75,000 | — | $0 | 221,969 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-12 | 2021-05-13 | 35,852 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-12 | 2021-05-13 | 35,852 | $4.73 | $169.6K | 146,127 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-11 | 2021-05-13 | 68,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-11 | 2021-05-13 | 1,648 | — | $0 | 35,852 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-11 | 2021-05-13 | 33,132 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-05-11 | 2021-05-13 | 102,780 | $12.04 | $1.24M | 110,275 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-11 | 2021-05-13 | 1,648 | $4.73 | $7.8K | 111,923 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-11 | 2021-05-13 | 33,132 | $1.42 | $47.0K | 145,055 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-11 | 2021-05-13 | 68,000 | $5.45 | $370.6K | 213,055 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-15 | 2020-12-17 | 280,000 | — | $0 | 280,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2020-12-11 | 2020-12-15 | 13,741 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2020-12-11 | 2020-12-15 | 13,741 | $7.96 | $109.4K | 108,061 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2020-12-11 | 2020-12-15 | 13,741 | $4.15 | $57.0K | 121,802 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2020-12-04 | 2020-12-08 | 13,741 | — | $0 | 13,741 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2020-12-04 | 2020-12-08 | 13,741 | $6.23 | $85.6K | 108,061 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2020-12-04 | 2020-12-08 | 13,741 | $4.15 | $57.0K | 121,802 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-03 | 2020-12-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-21 | 2020-02-25 | 12,400 | — | $0 | 12,400 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-14 | 2020-02-19 | 21,700 | — | $0 | 21,700 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-12-17 | 2019-12-19 | 190,000 | — | $0 | 190,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2019-11-18 | 2019-11-18 | 20,000 | $1.45 | $29.0K | 102,061 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2019-01-01 | 2019-01-03 | 423 | $8.07 | $3.4K | 77,530 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-12-20 | 2018-12-21 | 190,000 | — | $0 | 190,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-11-30 | 2018-12-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-11-30 | 2018-12-04 | 44,290 | $9.07 | $401.7K | 77,953 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-11-30 | 2018-12-04 | 25,000 | $1.42 | $35.5K | 122,243 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-05-15 | 2018-05-17 | 12,500 | — | $0 | 8,132 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-05-15 | 2018-05-17 | 3,004 | $5.91 | $17.8K | 95,264 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-05-15 | 2018-05-17 | 12,500 | $1.42 | $17.8K | 98,268 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 6,709 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-02-28 | 2018-03-02 | 6,709 | $3.26 | $21.9K | 85,768 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-20 | 2018-01-23 | 1,961 | $5.59 | $11.0K | 77,129 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-01 | 2018-01-03 | 459 | $4.91 | $2.3K | 79,090 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-12-20 | 2017-12-22 | 62,500 | — | $0 | 62,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-08-31 | 2017-09-05 | 18,600 | — | $0 | 18,600 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-02-27 | 2017-03-01 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-20 | 2017-01-24 | 2,599 | $5.95 | $15.5K | 75,497 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-01 | 2017-01-03 | 1,281 | $6.33 | $8.1K | 78,096 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2016-09-14 | 2016-09-16 | 8,357 | $4.27 | $35.7K | 79,377 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 91,004 | — | $0 | 91,004 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-03-01 | 2016-03-03 | 687 | $2.13 | $1.5K | 85,416 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2016-01-29 | 2016-02-01 | 19,368 | — | $0 | 20,632 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2016-01-29 | 2016-02-01 | 19,368 | $1.42 | $27.5K | 85,057 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-20 | 2016-01-22 | 2,599 | $7.55 | $19.6K | 65,689 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-01 | 2016-01-05 | 1,281 | $10.32 | $13.2K | 68,288 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-12-29 | 2015-12-31 | 43,997 | — | $0 | 43,997 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-19 | 2015-06-22 | 3,000 | $15.00 | $45.0K | 68,876 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-05-13 | 2015-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-03-01 | 2015-03-03 | 1,120 | $10.20 | $11.4K | 71,876 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-20 | 2015-01-22 | 2,210 | $11.17 | $24.7K | 72,370 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-01-01 | 2015-01-05 | 23,200 | — | $0 | 23,200 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-01-01 | 2015-01-05 | 4,800 | — | $0 | 77,033 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-01 | 2015-01-05 | 2,453 | $12.16 | $29.8K | 74,580 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-12-19 | 2014-12-23 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-05-26 | 2014-05-28 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-04 | 2014-03-07 | 2,518 | — | $0 | 27,482 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-04 | 2014-03-07 | 10,000 | — | $0 | 90,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-04 | 2014-03-07 | 12,500 | — | $0 | 37,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-03-04 | 2014-03-07 | 6,156 | — | $0 | 35,844 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-04 | 2014-03-07 | 6,156 | $6.68 | $41.1K | 99,838 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-04 | 2014-03-07 | 12,500 | $4.73 | $59.1K | 93,682 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-04 | 2014-03-07 | 10,000 | $1.42 | $14.2K | 112,356 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-03-04 | 2014-03-07 | 40,734 | $12.63 | $514.5K | 71,622 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-03-04 | 2014-03-07 | 2,518 | $4.15 | $10.4K | 102,356 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-03-01 | 2014-03-07 | 1,090 | $11.69 | $12.7K | 81,182 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-01-20 | 2014-02-04 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2014-01-20 | 2014-02-04 | 27,000 | — | $0 | 81,487 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-01-14 | 2014-01-15 | 13,500 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-01-14 | 2014-01-15 | 13,500 | $1.20 | $16.2K | 55,978 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-01-14 | 2014-01-15 | 1,491 | $10.87 | $16.2K | 54,487 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-01-01 | 2014-01-03 | 2,453 | $7.60 | $18.6K | 42,478 | SEC↗ |